Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Bioresorbable Vascular Scaffold Market Size (2024E): US$339.0 Mn
Projected Market Value (2031F):US$592.8 Mn
Global Market Growth Rate (CAGR 2024 to 2031):8.3%

Bioresorbable Vascular Scaffold Market - Report Scope:

Bioresorbable vascular scaffolds are innovative medical devices used in the treatment of coronary artery disease. These scaffolds are designed to provide temporary structural support to blood vessels and gradually dissolve over time, eliminating the need for permanent implants. The market caters to hospitals, cardiac centers, and specialized clinics, offering a range of scaffold types including polymer-based, metal-based, and hybrid scaffolds. Market growth is driven by increasing prevalence of cardiovascular diseases, advancements in scaffold materials and design, and rising demand for minimally invasive procedures.

Market Growth Drivers:

The global bioresorbable vascular scaffold market is propelled by several key factors, including the growing incidence of cardiovascular diseases and the need for effective and temporary solutions to support vessel healing. Technological advancements, such as the development of new biomaterials and improved scaffold designs, are enhancing treatment outcomes and patient safety. The rising preference for minimally invasive procedures is also driving demand for bioresorbable scaffolds. Additionally, increasing investments in research and development and favorable government initiatives aimed at improving cardiovascular care are further fueling market growth.

Market Restraints:

Despite promising growth prospects, the bioresorbable vascular scaffold market faces challenges related to high cost and limited reimbursement coverage. The complex manufacturing process and the advanced materials required for bioresorbable scaffolds contribute to higher costs, which can be a barrier to market adoption, especially in emerging economies. Moreover, the market encounters regulatory hurdles and safety concerns associated with long-term performance and biocompatibility of scaffolds. Addressing these challenges requires ongoing innovation, cost management strategies, and collaboration with healthcare providers and policymakers.

Market Opportunities:

The bioresorbable vascular scaffold market presents significant growth opportunities driven by technological innovations and expanding applications. Advances in scaffold materials, such as the development of novel polymers and bioactive coatings, are opening new avenues for market expansion. The increasing adoption of bioresorbable scaffolds in peripheral vascular interventions and the integration of digital health technologies, such as remote monitoring and personalized treatment plans, are enhancing patient outcomes and broadening market scope. Strategic partnerships, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and drive sustained market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
Which scaffold types and applications are driving bioresorbable scaffold adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the bioresorbable vascular scaffold market?
Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global bioresorbable vascular scaffold market?

Competitive Intelligence and Business Strategy:

Leading players in the global bioresorbable vascular scaffold market, including Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced scaffolds with improved biocompatibility, strength, and degradation profiles. Collaborations with research institutions, healthcare providers, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the evolving bioresorbable vascular scaffold landscape.

Key Companies Profiled:

Meril Life Sciences Pvt. Ltd.
Zeus Company LLC
Biotronik
Abbott
MicroPort Scientific Corporation
Kyoto Medical
Elixir Medical (MedImpact Healthcare Systems, Inc.)
Cigna
B. Braun Melsungen AG
Boston Scientific Corporation
REVA Medical

Bioresorbable Vascular Scaffold Market Segmentation

By Product

Metal Bioresorbable Vascular Scaffold
Polymer Bioresorbable Vascular Scaffold

By Application

Peripheral Artery
Coronary Artery

By End User

Hospitals
Ambulatory Care Centers
Cardiac Centers

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Product Code: PMRREP34715

1. Executive Summary

1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Disease Epidemiology
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Supply Chain Analysis
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis

4. Price Analysis, 2024

4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences

5. Global Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
- 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2031
5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
- 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
  - 5.3.3.1. Metal Bioresorbable Vascular Scaffold
  - 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
5.4. Market Attractiveness Analysis: Product
5.5. Global Bioresorbable Vascular Scaffold Market Outlook: Application
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
- 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
  - 5.5.3.1. Peripheral Artery
  - 5.5.3.2. Coronary Artery
5.6. Market Attractiveness Analysis: Application
5.7. Global Bioresorbable Vascular Scaffold Market Outlook: End User
- 5.7.1. Introduction / Key Findings
- 5.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
- 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
  - 5.7.3.1. Hospitals
  - 5.7.3.2. Ambulatory Care Centers
  - 5.7.3.3. Cardiac Centers
  - 5.7.3.4. Others
5.8. Market Attractiveness Analysis: End User

6. Global Bioresorbable Vascular Scaffold Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Application
- 7.2.4. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
- 7.4.1. Metal Bioresorbable Vascular Scaffold
- 7.4.2. Polymer Bioresorbable Vascular Scaffold
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
- 7.5.1. Peripheral Artery
- 7.5.2. Coronary Artery
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Care Centers
- 7.6.3. Cardiac Centers
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. Europe Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Application
- 8.2.4. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
- 8.4.1. Metal Bioresorbable Vascular Scaffold
- 8.4.2. Polymer Bioresorbable Vascular Scaffold
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
- 8.5.1. Peripheral Artery
- 8.5.2. Coronary Artery
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Care Centers
- 8.6.3. Cardiac Centers
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. East Asia Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Application
- 9.2.4. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
- 9.4.1. Metal Bioresorbable Vascular Scaffold
- 9.4.2. Polymer Bioresorbable Vascular Scaffold
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
- 9.5.1. Peripheral Artery
- 9.5.2. Coronary Artery
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Care Centers
- 9.6.3. Cardiac Centers
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Application
- 10.2.4. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
- 10.4.1. Metal Bioresorbable Vascular Scaffold
- 10.4.2. Polymer Bioresorbable Vascular Scaffold
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
- 10.5.1. Peripheral Artery
- 10.5.2. Coronary Artery
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Care Centers
- 10.6.3. Cardiac Centers
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Latin America Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Application
- 11.2.4. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
- 11.4.1. Metal Bioresorbable Vascular Scaffold
- 11.4.2. Polymer Bioresorbable Vascular Scaffold
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
- 11.5.1. Peripheral Artery
- 11.5.2. Coronary Artery
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Care Centers
- 11.6.3. Cardiac Centers
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 12.2.1. By Country
- 12.2.2. By Product
- 12.2.3. By Application
- 12.2.4. By End User
12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
- 12.4.1. Metal Bioresorbable Vascular Scaffold
- 12.4.2. Polymer Bioresorbable Vascular Scaffold
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
- 12.5.1. Peripheral Artery
- 12.5.2. Coronary Artery
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
- 12.6.1. Hospitals
- 12.6.2. Ambulatory Care Centers
- 12.6.3. Cardiac Centers
- 12.6.4. Others
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Meril Life Sciences Pvt. Ltd.
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Products
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Zeus Company LLC
- 13.3.3. Biotronik
- 13.3.4. Abbott
- 13.3.5. MicroPort Scientific Corporation
- 13.3.6. Kyoto Medical
- 13.3.7. Elixir Medical (MedImpact Healthcare Systems, Inc.)
- 13.3.8. Cigna
- 13.3.9. B. Braun Melsungen AG
- 13.3.10. Boston Scientific Corporation
- 13.3.11. REVA Medical

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations